Technopath Clinical Diagnostics is a leader in the research, development and supply of quality control materials for the medical device diagnostics industry.
Our growing and talented R&D team comprise scientists with a wide range of specialist technical capabilities, significant qualifications and industry experience in the development of consolidated quality control fluids for use within the diagnostic industry. We recently completed the fit-out of our new research and development laboratory which will be home to our future development efforts.
We continuously invest in developing new products and improved processes to meet the evolving demands of the IVD market place and grow our business. With our expertise in test consolidation and analyte stabilisation, utilising proprietary stabilisation techniques, we are able to develop high quality human based matrices for our products and to facilitate an industry leading level of test consolidation providing real value to our customers.
New Product Launches
Over the last 12 months we have developed and launched four new products:
- Multichem NB (Neonatal Bilirubin) Control
- Multichem AE (Ammonia/Ethanol) Control
- Multichem A1c (HbA1c) Control
- Multichem hsTn (high sensitive Troponin I & T) Control
Product Development Pipeline
Our current development pipeline of new products includes:
- DAU (Drugs of Abuse) Control
- AMH (Anti-Mullerian Hormone) Control /IVF (In-Vitro Fertilisation) Control
- Numerous Calibrators for IVD Clinical Chemistry Reagents
IAMQC Software Platform
We believe that informatics will play a key role in the evolution of the clinical diagnostics market place. Through our IAMQC software and its capability to link with all major diagnostic equipment platforms we believe we can provide high value QC software solutions to the industry. We are investing significant resources to enhance this platform and expand our reach.